Coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion in anaesthetised dogs

Cardiovascular Research

Volumn 16, Issue 2, 1982, Pages 99-106

  Tanabe, Masao ^a   Terashita, Zen Ichi ^a   Fujiwara, Shuji ^a   Shimamoto, Norio ^a   Goto, Noriko ^a   Nishikawa, Kohei ^a   Hirata, Minoru ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; IMIDAZOLE; INDOMETACIN; NORADRENALIN; PHENOXYBENZAMINE; PROSTAGLANDIN H2; RADIOISOTOPE; THROMBOXANE A2; THROMBOXANE B2;

ANIMAL EXPERIMENT; AUTONOMIC NERVOUS SYSTEM; BIOASSAY; CORONARY ARTERY BLOOD FLOW; DOG; HEART; HEART INFARCTION; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; PERIPHERAL VASCULAR SYSTEM; RADIOIMMUNOASSAY;

ANIMALS; BIOLOGICAL ASSAY; BLOOD PRESSURE; CATECHOLAMINES; CORONARY CIRCULATION; CORONARY DISEASE; DOGS; FEMALE; HEART RATE; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; PERFUSION; RABBITS; THROMBOXANE A2; THROMBOXANE B2; THROMBOXANES;

EID: 85047680641     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1093/cvr/16.2.99     Document Type: Review

References (23)

1. Anhut H, Bernauer W, Peskar BA. Radioimmunological determination of thromboxane release in cardiac anaphylaxis. Eur J Pharmacol 1977; 44: 85-8.
2. Beller GA, Smith TW, Hood Jr WB. Effects of ischemia and coronary reperfusion on myocardial digoxin uptake. Am J Cardiol 1975; 36: 902-7.
3. Berger HJ, Zaret BL, Speroff L, Cohen LS, Wolfson S. Regional cardial prostaglandin release during myocardial ischemia in anesthetized dogs. Circ Res 1976; 38: 566-71.
4. Blumenthal MR, Wang H, Liu LMP. Experimental coronary arterial occlusion and release. Effects on enzyme, electrocardiograms, myocardial contractility and reactive hyperemia. Am J Cardiol 1975; 36: 225-33.
5. 2 on strips of rabbit coeliac artery and certain other smooth muscle preparations. Br J Pharmacol 1976; 57: 462P.
6. 2. Science 1976; 193: 1135-7.
7. 2. Stroke 1977; 8: 480-3.
8. Hamberg M, Samuelsson B. Prostaglandin endoperoxides. Novel transformation of arachidonic acid in human platelets. Proc Natl Acad Sci USA 1974; 71: 3400-4.
9. Hamberg M, Svensson J, Samuelsson B. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA 1975; 72: 2994-8.
10. Jennings RB, Sommers HM, Smyth GA, Flack HA, Linn H. Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Arch Pathol 1960; 70: 68-78.
11. Kraemer RJ, Folts JD. Release of prostaglandin following temporary occlusion of the coronary artery. Fed Proc 1973; 32: 454.
12. Kraemer RJ, Phemetton TM, Folts JD. Prostaglandin-like substances in coronary venous blood following myocardial ischemia. J Pharmacol Exp Ther 1976; 199: 611-9.
13. Krug A, Rochemont WM, Korb G. Blood supply of the myocardium after temporary coronary occlusion. Circ Res 1966; 19: 57-62.
14. Moncada S, Bunting S, Mullane K, Thorogood P, Vane JR. Imidazole: A selective inhibitor of thromboxane synthetase. Prostaglandins 1977; 13: 611-18.
15. Needleman P, Minkes M, Raz A. Thromboxanes: Selective biosynthesis and distinct biological properties. Science 1976; 193: 163-5.
16. Needleman P, Kaley G. Cardiac and coronary prostaglandin synthesis and function. New Eng U Med 1978; 298: 1122-8.
17. Parker PE, Bashour FA, Downey HF, Kechejian SJ, Williams AG. Coronary hemodynamics during reperfusion following acute coronary ligation in dogs. Am Heart J 1975; 90: 593-9.
18. 2) in isolated, perfused kidneys of spontaneously hypertensive rats. Biochem Pharmacol 1979; 28: 3601-9.
19. Smith III EF, Lefer AM, Smith JB. Influence of thromboxane inhibition on the severity of myocardial ischemia in cats. Can J Physiol Pharmacol 1980; 58: 294-300.
20. 2 and prostaglandin h2: Potent stimulators of the swine coronary artery. Prostaglandins 1976; 12: 943-50.
21. Tanabe M, Fujiwara S, Ohta N, Shimamoto N, Hirata M. Pathophysiological significance of coronary collaterals for preservations of the myocardium during coronary occlusion and reperfusion in anesthetized dogs. Cardiovasc Res 1980; 14: 288-94.
22. 2 in isolated, working guinea pig heart. Eur J Pharmacol 1978; 53:49-56.
23. Vane JR. The use of isolated organs for detecting active substances in the circulating blood. Br J Pharmacol 1964; 23: 360-73.